admin
1127 POSTS2 COMMENTS
Sanofi establishes three-year collaboration with Stanford Medicine to accelerate immunology research
May 6, 2021: Sanofi has entered into a three-year research collaboration with Stanford University School of Medicine. Together, the...
Imfinzi, tremelimumab combo boosts survival in lung cancer
May 07, 2021: "POSEIDON was a Phase III trial of AstraZeneca’s Imfinzi (durvalumab) plus platinum-based chemotherapy or Imfinzi, tremelimumab and chemotherapy versus chemotherapy alone in...
Vectura and Inspira Sign Agreement to Develop Potential Inhaled Treatment for COVID-19
May 06, 2021: "Vectura Group plc, an industry leading inhalation CDMO, and Inspira Pharmaceuticals Limited, a new UK-based company focused on developing therapies...
Nirsevimab MELODY Phase III trial met primary endpoint of reducing RSV lower respiratory tract infections in healthy infants
April 26, 2021: The MELODY Phase III trial for nirsevimab met its primary endpoint of a statistically significant reduction in the incidence...
Zydus ‘Virafin’ receives Emergency Use Approval from DCGI moderate COVID-19 infection in adults
April 23, 2021: Zydus Cadila announced that the company has received Restricted Emergency Use Approval from the Drug Controller General of India...
Amarin receives great britain authorization for vazkepa from MHRA
Apr 22, 2021: "Amarin Corporation announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) has granted a Marketing Authorization for VAZKEPA...
BMS Invests in Europe with New Cell Therapy Manufacturing Site Planned in the Netherlands
April 22, 2021:Bristol Myers Squibb announced the company has selected Leiden, Netherlands to house a new cell therapy manufacturing site in Europe,...
FDA Continues Important Steps to Ensure Quality, Safety and Effectiveness of Authorized COVID-19 Vaccines
April 21, 2021: "The U.S. FDA takes its responsibility to ensure medical product quality, safety and effectiveness very seriously.
FDA Approves Immunotherapy for Endometrial Cancer with Specific Biomarker
April 22, 2021: "The U.S. FDA granted accelerated approval to Jemperli (dostarlimab) for treating patients with recurrent or advanced endometrial cancer that...
WHO launches effort to stamp out malaria in 25 more countries by 2025
April 21, 2021: Ahead of World Malaria Day, marked annually on 25 April, WHO congratulates the growing number of countries that are...
Novo Nordisk to initiate phase 3a development in obesity with oral semaglutide
April 21, 2021: "Novo Nordisk announced the decision to enter phase 3a development in obesity with oral semaglutide 50 mg.
Lilly and Incyte’s Baricitinib Improved Hair Regrowth for Alopecia Areata Patients
April 20, 2021: Eli Lilly and Company and Incyte announced results from a second Phase 3 trial (BRAVE-AA1) evaluating the efficacy and safety...
TOP AUTHORS
Most Read
Sanofi establishes three-year collaboration with Stanford Medicine to accelerate immunology research
May 6, 2021: Sanofi has entered into a three-year research collaboration with Stanford University School of Medicine. Together, the...
Imfinzi, tremelimumab combo boosts survival in lung cancer
May 07, 2021: "POSEIDON was a Phase III trial of AstraZeneca’s Imfinzi (durvalumab) plus platinum-based chemotherapy or Imfinzi, tremelimumab and chemotherapy versus chemotherapy alone in...
Vectura and Inspira Sign Agreement to Develop Potential Inhaled Treatment for COVID-19
May 06, 2021: "Vectura Group plc, an industry leading inhalation CDMO, and Inspira Pharmaceuticals Limited, a new UK-based company focused on developing therapies...
Nirsevimab MELODY Phase III trial met primary endpoint of reducing RSV lower respiratory tract infections in healthy infants
April 26, 2021: The MELODY Phase III trial for nirsevimab met its primary endpoint of a statistically significant reduction in the incidence...
